Diagnostic Criteria of ARDS at High Altitudes in Western China
1 other identifier
observational
3,000
1 country
1
Brief Summary
The severity of ARDS in high altitude areas was classified according to the Berlin standard high altitude area Oxygenation.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Dec 2019
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 1, 2019
CompletedFirst Submitted
Initial submission to the registry
December 30, 2019
CompletedFirst Posted
Study publicly available on registry
January 2, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2022
CompletedJanuary 2, 2020
December 1, 2019
1.1 years
December 30, 2019
December 31, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
ICU mortality
mortality during treatment in ICU
up to 24 weeks
28 days mortality
mortality at 28 days of hospitalization
up to 24 weeks
Secondary Outcomes (2)
Ventilator Free time
up to 24 weeks
Ventilator time
up to 24 weeks
Study Arms (3)
Mild ARDS
Oxygenation standards were calculated based on the Berlin diagnostic high element correction formula combined with local atmospheric pressure
Moderate ARDS
Oxygenation standards were calculated based on the Berlin diagnostic high element correction formula combined with local atmospheric pressure
Severe ARDS
Oxygenation standards were calculated based on the Berlin diagnostic high element correction formula combined with local atmospheric pressure
Eligibility Criteria
From 2019 to 2022, patients diagnosed with ARDS were admitted to the department of critical care medicine of qinghai university affiliated hospital, qinghai provincial people's hospital and other selected units
You may qualify if:
- age ≥18
- the primary disease of ARDS caused by systemic infection, shock, severe pneumonia, aspiration and trauma
- blood gas analysis showed a progressive decline in pulmonary ventilation function
You may not qualify if:
- Receive a large amount of hormone shock therapy in a short period of time
- Died within a short time (\< 24h) after mechanical ventilation
- Lack of data
- No chest imaging data
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Affiliated hospital of qinghai university
Xining, Qinghai, 810000, China
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Gan Guifen, Bachelor
Affiliated Hospital of Qinghai University
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- OTHER
- Target Duration
- 1 Month
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Chief physician
Study Record Dates
First Submitted
December 30, 2019
First Posted
January 2, 2020
Study Start
December 1, 2019
Primary Completion
December 31, 2020
Study Completion
December 31, 2022
Last Updated
January 2, 2020
Record last verified: 2019-12